Skip to main content

and
  1. Article

    Cost effectiveness of the type II Boston keratoprosthesis

    Despite demonstrated cost effectiveness, not all corneal disorders are amenable to type I Boston keratoprosthesis (KPro) implantation. This includes patients with autoimmune diseases, such as Stevens–Johnson s...

    J D Ament, T P Stryjewski, S Pujari, S Siddique, G N Papaliodis, J Chodosh in Eye (2011)